多色流式细胞术与融合基因转录本PCR检测KMT2A基因重排婴儿急性淋巴细胞白血病微小残留病的比较
该研究评估了多色流式细胞术(MFC)与融合基因转录本(FGT)PCR检测KMT2A基因重排婴儿急性淋巴细胞白血病微小残留病(MRD)的一致性。共分析123例婴儿的942份骨髓样本,最终一致率为87.4%。MFC-MRD可早期识别快速反应,FGT-MRD是后期治疗阶段可靠的复发预测指标,两种方法联合可最精确地定义风险。
要点
- MFC-MRD与FGT-MRD检测KMT2A-r婴儿ALL的MRD一致率为87.4%。
- MFC-MRD可早期识别快速反应,FGT-MRD在后期治疗阶段可靠预测复发。
- 两种方法联合可最精确地定义风险。
核心结论
- MFC-MRD与FGT-MRD检测KMT2A-r婴儿ALL的MRD结果高度可比,两者联合可最精确地定义风险。
研究设计与样本
- 研究纳入123例KMT2A基因重排婴儿急性淋巴细胞白血病患者,共检测942份骨髓样本的MFC-MRD和FGT-MRD。
主要发现
- 383份样本(40.7%)两种方法均检出MRD阴性。
- 441份样本(46.8%)两种方法均检出MRD阳性。
- 99份样本(10.5%)仅FGT-MRD阳性,19份样本(2.0%)仅MFC-MRD阳性。
- 最终一致率为87.4%。
- 不一致多发生于残留白血病水平接近检测灵敏度极限时;KMT2A融合类型或妨碍MFC方法的新型治疗未影响一致率。
临床怎么用
- 作者认为,由于两种方法结果高度可比,这两种相对简单且 inexpensive 的方法可作为具有高临床价值的良好选择。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
This study aimed to evaluate the concordance between minimal residual disease (MRD) results obtained by multicolour flow cytometry (MFC) and polymerase chain reaction for fusion gene transcripts (FGTs) in infants with acute lymphoblastic leukaemia (ALL) associated with rearrangement of the KMT2A gene (KMT2A-r). A total of 942 bone marrow (BM) samples from 123 infants were studied for MFC-MRD and FGT-MRD. In total, 383 samples (40.7%) were concordantly MRD-negative. MRD was detected by the two methods in 441 cases (46.8%); 99 samples (10.5%) were only FGT-MRD-positive and 19 (2.0%) were only MFC-MRD-positive. A final concordance rate of 87.4% was established. Most discordance occurred if residual leukaemia was present at levels close to the sensitivity limits. Neither the type of KMT2A fusion nor a new type of treatment hampering MFC methodology had an influence on the concordance rate. The prognostic value of MFC-MRD and FGT-MRD differed. MFC-MRD was able to identify a rapid response at early time-points, whereas FGT-MRD was a reliable relapse predictor at later treatment stages. Additionally, the most precise risk definition was obtained when combining the two methods. Because of the high comparability in results, these two rather simple and inexpensive approaches could be good options of high clinical value.
引用
- Popov A, Tsaur G, Verzhbitskaya T, et al. Comparison of minimal residual disease measurement by multicolour flow cytometry and PCR for fusion gene transcripts in infants with acute lymphoblastic leukaemia with KMT2A gene rearrangements. Br J Haematol. 2021. PMID: 34970734. doi:10.1111/bjh.18021
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。